Wave Life Sciences (WVE)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
Fundamental grade
Five factors scored 1 to 9 from WVE's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from Wave Life Sciences's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $41M | $4M | $113M | $108M | $43M |
| Net income | -$122M | -$162M | -$58M | -$97M | -$204M |
| Free cash flow | -$90M | -$129M | -$21M | -$152M | -$188M |
| EPS (diluted) | -$2.36 | -$2.05 | -$0.54 | -$0.70 | -$1.21 |
| Operating margin | -310.1% | -4459.3% | -60.0% | -101.9% | -504.1% |
Superinvestors who own WVE
From each investor's latest 13F filing (what a 13F shows). 4 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Lee Ainslie Maverick Capital |
Trimmed | $60M | 0.53% | Q2 2026 |
| PRIMECAP Management PRIMECAP Management Co |
Added | $31M | 0.02% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Added | $10M | 0.00% | Q2 2026 |
| Stanley Druckenmiller Duquesne Family Office |
Held | $1M | 0.02% | Q2 2026 |
Insider buying
Open-market purchases by Wave Life Sciences's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Dec 11, 2025 | Plc Gsk |
1,470,000 | $19.00 | $28M |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when WVE trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
Are Wave Life Sciences insiders buying the stock?
1 open-market insider purchase of WVE in the last 12 months, from SEC Form 4 filings.
Which superinvestors own Wave Life Sciences?
4 of the superinvestors Investingly tracks hold WVE in their latest 13F, including Lee Ainslie, PRIMECAP Management, Cliff Asness.
Companies like Wave Life Sciences
All Healthcare stocks · Biotechnology stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.